|
USP10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.589000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.689800E-01 |
| Normal-vs-Stage2 |
4.956200E-01 |
| Normal-vs-Stage3 |
9.614200E-02 |
| Normal-vs-Stage4 |
1.860020E-01 |
| Stage1-vs-Stage2 |
1.873440E-01 |
| Stage1-vs-Stage3 |
1.105580E-02 |
| Stage1-vs-Stage4 |
3.546400E-02 |
| Stage2-vs-Stage3 |
6.122800E-01 |
| Stage2-vs-Stage4 |
7.015800E-01 |
| Stage3-vs-Stage4 |
9.141400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.878200E-01 |
| Normal-vs-AfricanAmerican |
2.091600E-01 |
| Normal-vs-Asian |
8.069000E-01 |
| Caucasian-vs-AfricanAmerican |
3.280600E-01 |
| Caucasian-vs-Asian |
8.850800E-01 |
| AfricanAmerican-vs-Asian |
7.984400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.143500E-02 |
| Normal-vs-Female |
1.467780E-01 |
| Male-vs-Female |
1.462570E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.897800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.794600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.645010E-01 |
| Normal-vs-Age(81-100Yrs) |
9.175800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.637400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.410000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.101800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.685900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.714100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.873000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.468100E-02 |
| Normal-vs-Grade 2 |
5.168600E-01 |
| Normal-vs-Grade 3 |
3.740800E-01 |
| Normal-vs-Grade 4 |
1.377980E-02 |
| Grade 1-vs-Grade 2 |
2.210400E-01 |
| Grade 1-vs-Grade 3 |
1.492770E-01 |
| Grade 1-vs-Grade 4 |
2.146300E-02 |
| Grade 2-vs-Grade 3 |
1.382820E-01 |
| Grade 2-vs-Grade 4 |
6.579000E-03 |
| Grade 3-vs-Grade 4 |
7.571900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.546200E-02 |
| Normal-vs-ccB subtype |
1.960010E-01 |
| ccA subtype-vs-ccB subtype |
1.700570E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.425800E-01 |
| Normal-vs-N1 |
9.562600E-01 |
| N0-vs-N1 |
9.697200E-01 |
|
|
